Home/Investors/Public Shareholders (AIM)

Public Shareholders (AIM)

Biotech Investor · 2 portfolio companies

Portfolio
2
Combined Value
$495.6M
Focus Areas
4
Top Stage
Commercial

Portfolio Companies

CompanyValuation
Advanced Medical Solutions Group$419.8M
Bioventix$75.8M